PURPOSE: To examine big-bubble (BB) formation success rates in deep anterior lamellar keratoplasty (DALK) at various corneal depths using real-time guidance from swept-source, microscope-integrated optical coherence tomography (SS-MIOCT). METHODS: The DALK procedure was performed ex vivo with 34 human donor corneoscleral buttons on pressurized artificial anterior chambers using the BB technique employed by Anwar and Teichmann. We inserted a needle under controlled ex vivo conditions to corneal depths ranging from 40% to ≥90% using real-time guidance from SS-MIOCT and injected air. BB success was then determined for each injection. RESULTS: The average needle depth for successful full BB formation was 79.9% ± 3.0% compared with 66.9% ± 2.6% for partial BB formation and 49.9% ± 3.4% for no BB formation (P < 0.0001). Expressed as stroma below the needle tip, this corresponded to 123.9 ± 20.0 μm for successful full BB formation compared with 233.7 ± 23.8 μm for partial BB formation and 316.7 ± 17.3 μm for no BB formation (P < 0.0001). All other variables tested (sex, race, age, endothelial cell density, air injected, needle angle, and central corneal thickness) did not significantly affect BB formation success rates. CONCLUSIONS: BB formation in DALK is more successful if needle insertion and air injection occur at deeper corneal depth. However, ≥90% corneal depth was not necessary in this ex vivo model of DALK. SS-MIOCT can be used to accurately guide the needle in real time.
PURPOSE: To examine big-bubble (BB) formation success rates in deep anterior lamellar keratoplasty (DALK) at various corneal depths using real-time guidance from swept-source, microscope-integrated optical coherence tomography (SS-MIOCT). METHODS: The DALK procedure was performed ex vivo with 34 humandonor corneoscleral buttons on pressurized artificial anterior chambers using the BB technique employed by Anwar and Teichmann. We inserted a needle under controlled ex vivo conditions to corneal depths ranging from 40% to ≥90% using real-time guidance from SS-MIOCT and injected air. BB success was then determined for each injection. RESULTS: The average needle depth for successful full BB formation was 79.9% ± 3.0% compared with 66.9% ± 2.6% for partial BB formation and 49.9% ± 3.4% for no BB formation (P < 0.0001). Expressed as stroma below the needle tip, this corresponded to 123.9 ± 20.0 μm for successful full BB formation compared with 233.7 ± 23.8 μm for partial BB formation and 316.7 ± 17.3 μm for no BB formation (P < 0.0001). All other variables tested (sex, race, age, endothelial cell density, air injected, needle angle, and central corneal thickness) did not significantly affect BB formation success rates. CONCLUSIONS:BB formation in DALK is more successful if needle insertion and air injection occur at deeper corneal depth. However, ≥90% corneal depth was not necessary in this ex vivo model of DALK. SS-MIOCT can be used to accurately guide the needle in real time.
Authors: Bruce A Noble; Ashish Agrawal; Cian Collins; Manuel Saldana; Paul R Brogden; Bruno Zuberbuhler Journal: Cornea Date: 2007-01 Impact factor: 2.651
Authors: William J Reinhart; David C Musch; Deborah S Jacobs; W Barry Lee; Stephen C Kaufman; Roni M Shtein Journal: Ophthalmology Date: 2011-01 Impact factor: 12.079
Authors: Neel D Pasricha; Christine Shieh; Oscar M Carrasco-Zevallos; Brenton Keller; Joseph A Izatt; Cynthia A Toth; Anthony N Kuo Journal: Cornea Date: 2015-12 Impact factor: 2.651
Authors: Justis P Ehlers; Sunil K Srivastava; Daniel Feiler; Amanda I Noonan; Andrew M Rollins; Yuankai K Tao Journal: PLoS One Date: 2014-08-20 Impact factor: 3.240
Authors: Oscar M Carrasco-Zevallos; Christian Viehland; Brenton Keller; Mark Draelos; Anthony N Kuo; Cynthia A Toth; Joseph A Izatt Journal: Biomed Opt Express Date: 2017-02-21 Impact factor: 3.732
Authors: Paramjit K Bhullar; Oscar M Carrasco-Zevallos; Alexandria Dandridge; Neel D Pasricha; Brenton Keller; Liangbo Shen; Joseph A Izatt; Cynthia A Toth; Anthony N Kuo Journal: Asia Pac J Ophthalmol (Phila) Date: 2017 Sep-Oct
Authors: Asaf Achiron; Boris Knyazer; Boris E Malyugin; Alexandra Belodedova; Olga Antonova; Aslan Gelyastanov; Raimo Tuuminen; Eliya Levinger Journal: Graefes Arch Clin Exp Ophthalmol Date: 2022-07-28 Impact factor: 3.535
Authors: Yuan Tian; Mark Draelos; Ryan P McNabb; Kris Hauser; Anthony N Kuo; Joseph A Izatt Journal: Biomed Opt Express Date: 2022-08-31 Impact factor: 3.562
Authors: Brenton Keller; Mark Draelos; Kevin Zhou; Ruobing Qian; Anthony Kuo; George Konidaris; Kris Hauser; Joseph Izatt Journal: IEEE Trans Robot Date: 2020-04-16 Impact factor: 6.835
Authors: Mark Draelos; Gao Tang; Brenton Keller; Anthony Kuo; Kris Hauser; Joseph A Izatt Journal: IEEE Trans Biomed Eng Date: 2019-11-20 Impact factor: 4.538
Authors: Brenton Keller; Mark Draelos; Gao Tang; Sina Farsiu; Anthony N Kuo; Kris Hauser; Joseph A Izatt Journal: Biomed Opt Express Date: 2018-05-21 Impact factor: 3.732
Authors: Shoujing Guo; Nicolas R Sarfaraz; William G Gensheimer; Axel Krieger; Jin U Kang Journal: Sensors (Basel) Date: 2020-01-12 Impact factor: 3.576